Ovarian epithelial cancer metastatic – Life with Disease

Go back

Metastatic ovarian epithelial cancer represents the most advanced form of ovarian cancer, where the disease has spread beyond its original location to distant parts of the body, fundamentally changing the treatment approach and long-term outlook for patients.

Understanding the Prognosis

When ovarian epithelial cancer has metastasized, it means the disease has reached what doctors classify as Stage IV. At this advanced stage, cancer cells have traveled far from the ovaries to organs such as the liver, lungs, or even bones. Understanding what this means for your future is an important step in preparing both emotionally and practically for the journey ahead.[1]

The outlook for metastatic ovarian cancer depends heavily on individual circumstances. Your age, overall health, how well your cancer responds to treatment, and what treatment options are available to you all play significant roles in determining your outcome. These factors work together in complex ways that make each person’s experience unique.[7]

Statistics show that for invasive epithelial ovarian cancer diagnosed at Stage IV, the five-year relative survival rate is approximately 31 percent. This means that people with this type of cancer are 31 percent as likely to live at least five years as someone without the cancer. However, it’s crucial to understand that these numbers represent large groups of people and cannot predict what will happen in any individual case.[7]

The five-year survival rates are based on information about people diagnosed between 2012 and 2018, and outcomes often improve over time as new treatments become available. Some people with late-stage ovarian cancer survive more than 12 years after treatment and are considered cured in medical terms. While uncommon, these cases remind us that statistics tell only part of the story.[18]

⚠️ Important
Your doctor can provide a more personalized estimate based on your specific situation. While these conversations are difficult, having realistic information helps you make important decisions about your care, plan meaningful experiences with loved ones, and take care of practical matters such as legal documents.

How the Disease Progresses Without Treatment

Ovarian epithelial cancer typically follows a somewhat predictable path as it spreads through the body, though there is no single trajectory that applies to everyone. Understanding this progression helps explain why the disease is often not caught until later stages.[2]

In most cases, if ovarian cancer is not detected and treated in its early stages, it first moves from the ovaries to other parts of the pelvis. From there, it commonly spreads to more distant areas of the abdomen and into the peritoneal cavity, which is the space within the abdomen that contains organs like the intestines, stomach, and liver. The peritoneum is the thin tissue lining that covers these abdominal organs.[2]

As the disease continues, cancer cells often reach the lymph nodes, which are small bean-shaped structures that are part of the body’s immune system. The liver is frequently the next destination, followed by distant lymph nodes and the lungs. In some cases, the disease may eventually reach the bones or brain.[7]

One of the characteristic features of advanced ovarian cancer is the development of ascites, which is a buildup of fluid in the abdomen. This happens as the cancer spreads into the peritoneum and disrupts the normal balance of fluid in the abdominal cavity. The accumulation of fluid causes the abdomen to swell and can lead to discomfort, difficulty eating, and a feeling of fullness even after small meals.[3]

High-grade serous ovarian cancer, the most common and aggressive subtype of epithelial ovarian cancer, behaves particularly aggressively once it reaches the ovaries. Although experts believe this type grows slowly at first, usually starting in the fallopian tubes, it spreads quickly once it involves the ovaries. Nearly 70 percent of high-grade serous ovarian cancer cases are already at stage 3 or 4 by the time they are diagnosed, meaning the cancer has spread to nearby organs and lymph nodes or beyond.[3]

Without treatment, the disease continues to spread and grow, eventually affecting multiple organ systems. This widespread involvement makes it increasingly difficult for the body to function normally and leads to worsening symptoms that significantly impact quality of life.

Possible Complications

Metastatic ovarian epithelial cancer brings with it a range of complications that can affect different parts of the body and create new challenges beyond the cancer itself. These complications can significantly impact how you feel day to day and may require their own specific treatments.[6]

One of the most common complications is malignant pleural effusion, which occurs when cancer causes fluid to build up in the lining of the lungs. This is actually part of the definition of Stage 4a ovarian cancer. When fluid accumulates around the lungs, it becomes difficult to breathe deeply, leading to shortness of breath, chest discomfort, and reduced exercise tolerance. Doctors can drain this fluid to provide relief, but it often accumulates again over time.[6]

Bowel obstruction is another serious complication that can develop as tumors grow in the abdomen and press on or invade the intestines. When the bowel becomes blocked, it can cause severe abdominal pain, nausea, vomiting, inability to pass gas or stool, and severe bloating. This complication may require surgery or other interventions to restore normal bowel function or manage symptoms.[6]

The buildup of fluid in the abdomen, known as ascites, becomes increasingly problematic as the cancer progresses. Large amounts of fluid can make the abdomen extremely distended and tight, causing significant discomfort, difficulty breathing when the fluid pushes on the diaphragm, problems eating adequate amounts of food, and difficulty moving around comfortably. The fluid may need to be drained periodically through a procedure called paracentesis.[3]

When cancer spreads to the liver, it can interfere with this vital organ’s many functions, including processing nutrients, filtering toxins from the blood, and producing proteins needed for blood clotting. Liver involvement can cause jaundice, where the skin and eyes take on a yellowish color, along with fatigue, confusion, and bleeding problems.[2]

Lung metastases can cause persistent coughing, chest pain, and progressive difficulty breathing. Bone metastases, though less common in ovarian cancer, can lead to severe pain, increased risk of fractures, and elevated calcium levels in the blood, which causes its own set of problems including confusion, kidney issues, and heart rhythm abnormalities.[7]

Many people with advanced cancer also develop blood clots, particularly in the legs, which can be painful and dangerous if they break loose and travel to the lungs. The cancer and its treatments can also lead to severe fatigue, weight loss, weakness, and increased susceptibility to infections as the immune system becomes compromised.

Impact on Daily Life

Living with metastatic ovarian epithelial cancer touches every aspect of daily existence, from the most basic physical activities to emotional wellbeing, relationships, work, and leisure pursuits. The disease and its treatments create a new reality that requires constant adjustment and adaptation.[17]

Physically, the symptoms of advanced ovarian cancer can be exhausting and limiting. The persistent abdominal bloating and discomfort can make it difficult to find comfortable positions for sitting or sleeping. Eating becomes a challenge when you feel full quickly or experience nausea. The fatigue that accompanies advanced cancer is unlike ordinary tiredness—it’s a bone-deep exhaustion that doesn’t improve with rest and can make even simple tasks like showering or preparing a meal feel overwhelming.[3]

Pain management becomes a daily consideration. Depending on where the cancer has spread, you might experience abdominal pain, back pain, chest discomfort, or bone pain. Finding the right balance of pain medications that provide relief without causing unacceptable side effects often requires ongoing adjustments and close communication with your healthcare team.[18]

The emotional and mental toll can be just as significant as the physical challenges. Many people experience waves of anxiety, particularly when waiting for test results or facing decisions about treatment. Depression is common and understandable when dealing with a serious illness that threatens your life and changes your future plans. Fear about the future, anger at the unfairness of the situation, and grief for the life you had planned are all normal responses to this diagnosis.[7]

Relationships with family and friends often shift in unexpected ways. Some people may struggle to know what to say or how to help, while others may become uncomfortable with the reality of serious illness. At the same time, you may find that certain relationships deepen and become more meaningful as people show up to support you in practical and emotional ways. The change in your role within your family—perhaps from being the primary caregiver to needing care yourself—can be particularly difficult to navigate.

Work life almost always requires adjustments. Some people find they need to reduce their hours, take extended leave, or stop working entirely depending on how they feel and how demanding their treatment schedule becomes. The loss of work can mean loss of income, health insurance concerns, and a sense of purpose and normalcy that work provides. Even if you can continue working, you may find it difficult to concentrate or maintain your previous level of performance.[17]

Hobbies and activities you once enjoyed may become difficult or impossible. Physical activities like sports, gardening, or traveling require energy and physical capability that the disease may have taken away. Even quieter pursuits like reading or crafts can be challenging when you’re dealing with fatigue, difficulty concentrating, or uncomfortable symptoms.

There are strategies that can help you cope with these limitations. Breaking tasks into smaller steps and resting between activities can help you accomplish more without becoming overwhelmed. Accepting help from others, even when it feels uncomfortable, allows you to conserve energy for what matters most to you. Being honest with friends and family about what you need—whether that’s practical help, emotional support, or simply quiet company—helps them know how to support you. Connecting with other people who have ovarian cancer, either through support groups or online communities, can reduce feelings of isolation and provide practical tips from those who understand what you’re experiencing.

Support for Family and Finding Clinical Trials

Families play a crucial role in supporting someone with metastatic ovarian cancer, and understanding clinical trials represents an important part of that support. Clinical trials offer access to new treatments that aren’t yet widely available and may provide options when standard treatments have stopped working or aren’t suitable.[14]

Clinical trials are research studies that test new approaches to preventing, detecting, or treating cancer. For metastatic ovarian cancer, trials might investigate new chemotherapy drugs, targeted therapies that attack specific features of cancer cells, immunotherapy approaches that help the immune system fight cancer, or new combinations of existing treatments. Some trials also study better ways to manage symptoms and side effects.[16]

Families should understand that participating in a clinical trial is always voluntary. The decision to join a trial is a personal one that should be made after carefully considering the potential benefits and risks, understanding what participation will involve, and discussing all options with the healthcare team. Clinical trials have strict eligibility criteria, and not every patient will qualify for every trial.[14]

Family members can help by researching available clinical trials. The National Cancer Institute’s website maintains a comprehensive database of cancer clinical trials happening across the country. Other resources include ClinicalTrials.gov, cancer center websites, and advocacy organizations focused on ovarian cancer. When you find trials that might be relevant, you can discuss them with the patient’s oncologist to determine whether they might be appropriate.[4]

Helping prepare for trial participation involves several practical steps. Family members can assist with gathering and organizing medical records, which trials will need to review. Keeping track of all previous treatments, including dates and responses, helps trial coordinators determine eligibility. Transportation to appointments becomes especially important since clinical trials often require more frequent visits than standard care. Having a family member attend appointments to help listen, take notes, and ask questions ensures important information doesn’t get missed.[14]

Understanding the structure of clinical trials helps families know what to expect. Most cancer treatment trials have phases. Phase I trials test safety and dosing of new treatments in small groups. Phase II trials look at whether treatments work and continue monitoring safety. Phase III trials compare new treatments to standard treatments in larger groups. Each phase answers different questions and involves different levels of known and unknown risks.

Families should help their loved one understand informed consent, which is the process of learning key facts about a trial before deciding whether to participate. This includes understanding the trial’s purpose, what treatments and tests will be involved, potential risks and benefits, alternatives to participating, and the right to leave the trial at any time. Taking time to read consent documents carefully and asking questions about anything unclear is essential.[14]

Emotional support remains equally important. Clinical trial participation can bring hope, but it also involves uncertainty. The treatment being tested may not work, and there may be unexpected side effects. Helping your loved one weigh these considerations while respecting their autonomy in making the decision requires sensitivity and patience. Some people feel strongly about contributing to research that might help others in the future, even if they don’t benefit directly, while others focus primarily on their own potential benefit.

Practical support matters tremendously. Clinical trials often involve more appointments, additional tests, and careful monitoring. Family members can help by driving to appointments, helping track symptoms and side effects that need to be reported, organizing medications and schedules, and communicating with the research team when needed. Keeping a calendar of appointments and a notebook of questions helps everyone stay organized.

It’s also important for families to maintain perspective. Clinical trials offer hope and possibilities, but they’re not right for everyone or available to everyone. If your loved one doesn’t qualify for a trial or chooses not to participate, other treatment options exist. Supporting whatever decision they make, whether that’s pursuing a clinical trial, continuing with standard treatment, or focusing on comfort care, demonstrates respect for their values and wishes.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Bevacizumab (Avastin) – A monoclonal antibody that targets the VEGF/VEGFR pathway and inhibits tumor blood vessel growth, approved for patients with newly diagnosed and relapsed ovarian cancer
  • Mirvetuximab soravtansine (Elahere) – An antibody-drug conjugate that targets the folate receptor pathway and delivers toxic drugs to tumors, approved for subsets of patients with advanced ovarian cancer
  • Dostarlimab (Jemperli) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved for subsets of patients with advanced ovarian cancer that has DNA mismatch repair deficiency
  • Pembrolizumab (Keytruda) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved for subsets of patients with advanced ovarian cancer with high microsatellite instability or DNA mismatch repair deficiency
  • Carboplatin – A platinum-based chemotherapy drug used as standard first-line treatment, typically combined with paclitaxel
  • Paclitaxel – A taxane-based chemotherapy drug used as standard first-line treatment, typically combined with carboplatin

Ongoing Clinical Trials on Ovarian epithelial cancer metastatic

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    1 1
    Investigated drugs:
    Belgium France Spain

References

https://www.ncbi.nlm.nih.gov/books/NBK567760/

https://ocrahope.org/news/metastatic-ovarian-cancer/

https://my.clevelandclinic.org/health/diseases/22250-epithelial-ovarian-cancer

https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq

https://www.uhhospitals.org/services/cancer-services/gynecologic-cancer/ovarian-cancer/about-ovarian-cancer

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/stages-grades/stage-4

https://www.medicalnewstoday.com/articles/metastatic-ovarian-cancer

https://www.cancer.northwestern.edu/types-of-cancer/gynecologic/ovarian.html

https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq

https://pubmed.ncbi.nlm.nih.gov/39013199/

https://www.masseycancercenter.org/cancer-types-and-treatments/cancer-types/ovarian-cancer/treatment/

https://www.cancer.org/cancer/types/ovarian-cancer/treating/targeted-therapy.html

https://jeccr.biomedcentral.com/articles/10.1186/1756-9966-31-14

https://cancerblog.mayoclinic.org/2024/05/01/ovarian-cancer-new-treatments-and-research/

https://my.clevelandclinic.org/health/diseases/22250-epithelial-ovarian-cancer

https://www.cancerresearch.org/immunotherapy-by-cancer-type/ovarian-cancer

https://www.cancer.org/cancer/types/ovarian-cancer/after-treatment.html

https://www.webmd.com/ovarian-cancer/ovarian-cancer-late-stage

https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq

https://www.ncbi.nlm.nih.gov/books/NBK567760/

https://www.myovariancancerteam.com/resources/what-you-need-to-know-about-epithelial-ovarian-cancer-symptoms-treatment-and-prognosis

https://www.cancerresearch.org/immunotherapy-by-cancer-type/ovarian-cancer

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/stages-grades/stage-4

FAQ

Where does ovarian cancer typically spread first when it metastasizes?

Ovarian cancer typically spreads first to other parts of the pelvis, then to more distant areas of the abdomen and peritoneal cavity, followed by the lymph nodes and liver. The lungs, bones, and brain are also potential sites of metastasis. There is no single path that applies to all cases, but the liver is the most common distant organ for ovarian cancer to reach, followed by distant lymph nodes and the lungs.

Can metastatic ovarian cancer ever be cured?

While it’s uncommon, some people with metastatic ovarian cancer can be cured. Approximately 20 percent of those with late-stage ovarian cancer survive more than 12 years after treatment and are considered cured in medical terms. Treatment options including surgery, chemotherapy, and targeted therapies can sometimes result in long-term remission even when cancer has spread to distant organs.

What is the difference between Stage 4a and Stage 4b ovarian cancer?

Stage 4a ovarian cancer means the cancer has caused fluid buildup in the lining of the lungs, called a malignant pleural effusion. Stage 4b means the cancer has spread to the inside of the liver or spleen, lymph nodes outside the abdomen, or other organs such as the lungs. Both represent metastatic disease but differ in the specific locations involved.

Should I continue treatment if my ovarian cancer has metastasized?

Having Stage IV ovarian cancer doesn’t necessarily mean you should give up on treatment. Treatment can often help you feel better and possibly live longer. Treatment options may include surgery, chemotherapy, targeted medications, and clinical trials. Even when cure isn’t the goal, treatments can be used as palliative care to relieve symptoms like pain, fatigue, and digestive issues. Your doctor will help you determine whether continuing treatment makes sense based on your individual situation.

What new treatments are available for metastatic ovarian cancer?

Several newer treatments have been approved for metastatic ovarian cancer beyond traditional chemotherapy. These include bevacizumab, a monoclonal antibody that prevents tumor blood vessels from growing; mirvetuximab soravtansine, an antibody-drug conjugate for certain advanced cases; and checkpoint inhibitors like dostarlimab and pembrolizumab for patients whose tumors have specific genetic features. PARP inhibitors are also used as maintenance therapy to delay or prevent disease relapse after chemotherapy.

🎯 Key takeaways

  • Metastatic ovarian epithelial cancer represents Stage IV disease where cancer has spread to distant organs like the liver, lungs, or bones
  • The five-year relative survival rate for Stage IV invasive epithelial ovarian cancer is approximately 31 percent, though individual outcomes vary widely
  • About 20 percent of people with late-stage ovarian cancer survive more than 12 years and are considered cured, showing that long-term survival is possible
  • Common complications include fluid buildup around the lungs and in the abdomen, bowel obstruction, and impaired organ function
  • Treatment options for metastatic disease include surgery, chemotherapy, targeted therapies like bevacizumab, and clinical trials testing new approaches
  • The disease significantly impacts physical abilities, emotional wellbeing, relationships, work, and daily activities, requiring ongoing adaptation
  • Family members can provide crucial support by helping research clinical trials, organizing medical information, providing transportation, and offering emotional support
  • Even when cure isn’t possible, palliative treatments can improve quality of life by managing pain, breathing difficulties, and other symptoms

Connected medications: